def14a
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No. )
Filed by the Registrant þ
Filed by a Party other than the Registrant o
Check the appropriate box:
o |
|
Preliminary Proxy Statement |
o |
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
þ |
|
Definitive Proxy Statement |
o |
|
Definitive Additional Materials |
o |
|
Soliciting Material Pursuant to §240.14a-12 |
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
þ |
|
No fee required. |
|
o |
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
|
(1) |
|
Title of each class of securities to which transaction applies: |
|
|
|
|
|
|
|
(2) |
|
Aggregate number of securities to which transaction applies: |
|
|
|
|
|
|
|
(3) |
|
Per unit price or other underlying value of transaction
computed pursuant to Exchange Act Rule 0-11 (set forth the
amount on which the filing fee is calculated and state how it
was determined): |
|
|
|
|
|
|
|
(4) |
|
Proposed maximum aggregate value of transaction: |
|
|
|
|
|
|
|
(5) |
|
Total fee paid: |
|
|
|
|
|
o |
|
Fee paid previously with preliminary materials. |
|
o |
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the
filing for which the offsetting fee was paid previously. Identify the previous filing by registration
statement number, or the Form or Schedule and the date of its filing. |
|
(1) |
|
Amount Previously Paid: |
|
|
|
|
|
|
|
(2) |
|
Form, Schedule or Registration Statement No.: |
|
|
|
|
|
|
|
(3) |
|
Filing Party: |
|
|
|
|
|
|
|
(4) |
|
Date Filed: |
|
|
|
|
|
|
|
|
|
Persons who are to respond to the collection of information
contained in this form are not required to respond unless the
form displays a currently valid OMB control number. |
SYNERGETICS
USA, INC.
3845 Corporate Centre Drive
OFallon, Missouri 63368
November 13, 2007
Dear Stockholder:
You are cordially invited to attend our Companys 2007
Annual Meeting of Stockholders, which will be held on
December 6, 2007, at 4:30 p.m. Central Time at
The Doubletree Hotel and Conference Center located at 16625
Swingley Ridge Road, Chesterfield, Missouri 63017. The formal
Notice of Annual Meeting of Stockholders and Proxy Statement
accompanying this letter describe the business to be acted upon
at the meeting.
Your vote is important to us and your shares should be
represented at the meeting whether or not you are personally
able to attend. Accordingly, I encourage you to mark, sign, date
and return the accompanying proxy promptly.
On behalf of the Board of Directors, thank you for your
continued support of Synergetics USA, Inc.
Sincerely,
GREGG D. SCHELLER
Chairman, President and Chief Executive Officer
SYNERGETICS
USA, INC.
NOTICE OF ANNUAL MEETING OF
STOCKHOLDERS
To Be Held on December 6,
2007
NOTICE IS HEREBY GIVEN that the 2007 Annual Meeting of
Stockholders of Synergetics USA, Inc., a Delaware corporation
(the Company), will be held on December 6,
2007, at 4:30 p.m. Central Time at The Doubletree
Hotel and Conference Center located at 16625 Swingley Ridge
Road, Chesterfield, Missouri 63017 to act upon the following
matters, which are described more fully in the accompanying
Proxy Statement:
1. The election of two (2) directors nominated by the
Synergetics Nominating and Governance Committee to serve
three year terms following approval by the shareholders at the
next Annual Meeting;
2. The ratification of the Companys independent
registered accounting firm, UHY LLP; and
3. Such other business as may properly come before the
meeting
and/or any
adjournment or postponement thereof.
All holders of common stock of record at the close of business
on November 7, 2007 are entitled to notice of, and to vote
at, the Annual Meeting or any adjournment or postponement
thereof.
The Board of Directors of the Company has authorized the
solicitation of proxies. Unless otherwise directed, the proxies
will be voted FOR the election of the nominees listed in the
attached Proxy Statement to be members of the Board of Directors
of the Company and on other business that may properly come
before the Annual Meeting, as the named proxies in their best
judgment shall decide.
Any stockholder submitting a proxy may revoke such proxy at any
time prior to its exercise by notifying the Secretary of the
Company in writing at 3845 Corporate Centre Drive,
OFallon, Missouri, 63368, prior to the Annual Meeting,
and, if you attend the Annual Meeting, you may revoke your proxy
if previously submitted and vote in person by notifying the
Secretary of the Company at the Annual Meeting.
This Notice of Annual Meeting and Proxy Statement and form of
proxy are being distributed on or about November 13, 2007.
By Order of the Board of Directors,
PAMELA G. BOONE
Secretary
OFallon, Missouri
November 13, 2007
YOUR VOTE IS IMPORTANT
Whether or not you plan to attend the Annual Meeting, we
encourage you to read this proxy statement and submit your proxy
as soon as possible. You may submit your proxy for the Annual
Meeting by completing, signing, dating and returning your proxy
in the pre-addressed envelope provided.
SYNERGETICS
USA, INC.
PROXY
STATEMENT
FOR THE
2007 ANNUAL MEETING OF STOCKHOLDERS
TABLE OF CONTENTS
GENERAL
INFORMATION
This Proxy Statement is being furnished in connection with the
solicitation of proxies by the Board of Directors of Synergetics
USA, Inc., a Delaware corporation (the Company),
3845 Corporate Centre Drive, OFallon, Missouri, 63368, for
use at the 2007 Annual Meeting of Stockholders to be held on
December 6, 2007 at 4:30 p.m. Central Time at The
Doubletree Hotel and Conference Center located at 16625 Swingley
Ridge Road, Chesterfield, Missouri 63017. The Board of Directors
of the Company urges you to promptly execute and return your
proxy in the enclosed envelope, even if you plan on attending
the Annual Meeting. This is designed to authenticate
stockholders identities, to allow stockholders to give
their voting instructions and to confirm that stockholders
instructions have been recorded properly.
Any stockholder submitting a proxy may revoke such proxy at any
time prior to its exercise by notifying the Secretary of the
Company, in writing, prior to the Annual Meeting. Any
stockholder attending the Annual Meeting may revoke his or her
proxy and vote personally by notifying the Secretary of the
Company at the Annual Meeting. Only stockholders of record at
the close of business on November 7, 2007, will be entitled
to notice of, and to vote at, the Annual Meeting or any
adjournment or postponement thereof. At the close of business on
November 7, 2007, the Company had 24,274,500 outstanding
shares of common stock, $.001 par value per share (the
Common Stock). Each share of Common Stock entitles
the holder thereof to one vote.
If the accompanying proxy card is signed and returned, the
shares represented thereby will be voted in accordance with the
directions on the proxy card. Unless a stockholder specifies
otherwise therein, the proxy will be voted in accordance with
the recommendations of the Board of Directors on all proposals.
The presence in person or by proxy of a majority of the voting
power represented by outstanding shares of Common Stock will
constitute a quorum for the transaction of business at the
Annual Meeting.
Directors will be elected by a plurality of the voting power
represented and entitled to vote at the meeting. The passage of
any other proposal will be determined by the affirmative vote of
the majority of the voting power represented and entitled to
vote at the meeting. In the election of directors, abstentions
and broker non-votes will not affect the outcome except in
determining the presence of a quorum; they will not be counted
toward the number of votes required for any nominees
election. An instruction to abstain from voting on
any other proposal will have the same effect as a vote against
the proposal. Broker non-votes will not be considered as present
and entitled to vote on the proposals; therefore, broker
non-votes will have no effect on the number of affirmative votes
required to adopt such proposal.
This Proxy Statement and the enclosed proxy card are being
mailed to the stockholders of the Company on or about
November 13, 2007.
PROPOSAL 1
ELECTION OF DIRECTORS
The Board of Directors of the Company currently consists of
seven (7) directors. The directors are elected to serve
three-year staggered terms. The terms of Lawrence C. Cardinale
and Guy R. Guarch expire at the 2007 Annual Meeting. Mssrs.
Cardinale and Guarch have been nominated for re-election. The
Board of Directors of the Company recommends a vote FOR the two
(2) nominees. If re-elected, each nominee will serve until
the annual election of directors in the year 2010 or until his
successor is duly elected and qualified, or his earlier death,
resignation or removal. If any of the nominees are unavailable
for election, an event which the Board of Directors of the
Company does not presently anticipate, the persons named in the
enclosed proxy intend to vote the proxies solicited hereby FOR
the election of such other nominee or nominees as may be
nominated by the Board of Directors.
Based on the recommendation of the Nominating and Corporate
Governance Committee, all of the nominees have been approved
unanimously by the Board of Directors of the Company for
re-election. The Board of Directors of the Company has also
determined that each of the nominees satisfies the definition of
an independent director set forth in the marketplace
rules of The NASDAQ Stock Market, Inc. (Nasdaq). Set
forth below is information concerning the two (2) nominees
for director and the directors whose terms are continuing.
Nominees
for Directors to be Re-Elected at the 2007 Annual Meeting for
Terms expiring in 2010
|
|
|
|
|
|
|
|
|
|
|
Name
|
|
Age
|
|
Principal Occupation and Other Information
|
|
Expiration of Term
|
|
Lawrence C. Cardinale
|
|
|
69
|
|
|
Lawrence C. Cardinale has served as a director of the Company
since 2005 when Synergetics, Inc. merged with Valley Forge
Scientific Corp. (Valley Forge) (now known as
Synergetics USA, Inc. or the Company).
Mr. Cardinale received his B.S.B.A. in Business from
Washington University in St. Louis, Missouri and has
recently retired after working in the medical industry since
1966. During his over 35 years working in the field of
medical manufacturing, he held various management positions,
including Plant Manager, Director of Manufacturing, Director of
Corporate Engineering, Director of Operations Planning, Vice
President of Manufacturing-International and Vice
President-Global Manufacturing and Engineering of a
multi-national medical manufacturing company. Mr. Cardinale
also owned and operated a scientific laboratory instrument
business concentrating in the life sciences area, which
manufactured and marketed tissue sectioning, microforge and
micromanipulation instruments and pipeting devices.
Mr. Cardinale currently serves as a board member of
Coretech-Holdings LLC, a St. Louis-based life sciences and
medical device manufacturing company and McCormick Scientific,
LLC.
|
|
|
2010
|
|
Guy R. Guarch
|
|
|
66
|
|
|
Guy R. Guarch has been a director of the Company since 2005,
when Synergetics, Inc. merged with Valley Forge. Mr. Guarch
retired in 2001 from C.R. Bard, Inc. where he spent
32 years in various sales, marketing and management roles.
Bard is a leading developer, manufacturer and marketer of health
care products used for vascular, urological and oncological
diagnosis and intervention. From 1993 to 2001, Mr. Guarch
served as Regional Vice President Corporate Account Manager for
Bards Southeast Region. He worked as President of Bard
Venture Division in Boston, Massachusetts from 1991 to 1993.
From 1988 to 1991, Mr. Guarch worked in London, England, as
Vice President of Sales for the Bard Europe Division and
Managing Director of Bard LTD, UK. Before 1988, Mr. Guarch
worked in several sales and marketing roles for Bards USCI
International Division in Boston, Massachusetts, which focused
on the design, manufacture and sale of cardiac catheters,
urological catheters and artificial arteries. Mr. Guarch
currently serves as a board member and chairman of their
governance committee for
Span-America
Medical Systems, Inc., which designs and manufactures wound
management products and which has securities registered pursuant
to Section 12 of the Securities Exchange Act of 1934 (the
Exchange Act).
|
|
|
2010
|
|
2
Directors
whose Terms Continue through the 2007 Annual Meeting
|
|
|
|
|
|
|
|
|
|
|
Name
|
|
Age
|
|
Principal Occupation and Other Information
|
|
Expiration of Term
|
|
Robert H. Dick
|
|
|
63
|
|
|
Mr. Dick has been a director of the Company since 2005,
when Synergetics, Inc. merged with Valley Forge. Prior to the
merger, Mr. Dick had been a director of Valley Forge since
1997. Mr. Dick has served as President of R.H.
Dick & Company since January 1998, which is an
investment banking and management consulting firm based in Camp
Verde, Texas. From 1996 to 1998, he was a partner with Boles,
Knop & Company, Inc., an investment banking firm in
Middleburg, Virginia. From 1994 to 1996, Mr. Dick served as
interim President, Chief Executive Officer and Chief Financial
Officer of two Boles clients. From 1982 until 1994, he
served in various executive roles with Codman &
Shurtleff, Inc., a subsidiary of Johnson & Johnson and
a manufacturer of surgical instruments, implants, equipment and
other surgical products. From 1978 to 1982, Mr. Dick was
President and Chief Executive Officer of Applied Fiberoptics,
Inc., a company designing, manufacturing and marketing
fiberoptic products for medical and defense applications, and
surgical microscopes for microsurgery. From 1969 to 1978,
Mr. Dick held various sales, marketing and general
management positions with the USCI division of C.R. Bard.
Mr. Dick also serves on the board, chairman of their audit
committee and member of the executive and governance committees
for
Span-America
Medical Systems, Inc., which designs and manufactures wound
management products and which has securities registered pursuant
to Section 12 of the Exchange Act.
|
|
|
2009
|
|
Juanita H. Hinshaw
|
|
|
62
|
|
|
Juanita H. Hinshaw has served as a director of the Company since
2005 when Synergetics, Inc. merged with Valley Forge.
Ms. Hinshaw has been President and Chief Executive Officer
of H&H Advisors (a financial advisory company) since 2005.
In addition, Ms. Hinshaw served as Senior Vice President
and Chief Financial Officer of Graybar Electric Company from May
2000 to May 2005. Graybar Electric Company specializes in supply
chain management services and distributes high-quality
components, equipment and materials for the electrical and
telecommunications industries. Ms. Hinshaw has served as a
director on the board, chairman of the finance committee and
served on the audit committee for The Williams Companies, Inc.
since 2004 and has served as a director on the board, chairman
of the compensation committee and served on the audit committee
for Insituform Technologies, Inc. since 1999. The Williams
Company and Insituform Technologies, Inc. have securities
registered pursuant to Section 12 of the Exchange Act.
|
|
|
2009
|
|
Gregg D. Scheller
|
|
|
52
|
|
|
Gregg D. Scheller is the Companys President and Chief
Executive Officer and has served as the Companys Chairman
of the Board since 2005. Immediately prior to the consummation
of the merger with Valley Forge, Mr. Scheller served as
President and Chief Executive Officer of Synergetics, Inc., a
Missouri corporation and now a wholly-owned subsidiary of the
Company, which he founded in 1991. Mr. Scheller had served
in these positions since Synergetics, Inc. was founded in 1991.
Mr. Scheller has been issued 29 United States patents
(including four design patents).
|
|
|
2008
|
|
3
|
|
|
|
|
|
|
|
|
|
|
Name
|
|
Age
|
|
Principal Occupation and Other Information
|
|
Expiration of Term
|
|
Kurt W. Gampp, Jr.
|
|
|
47
|
|
|
Kurt W. Gampp, Jr. is the Companys Executive Vice
President and Chief Operating Officer and has served in these
positions and as a director since 2005. Immediately prior to the
merger with Valley Forge, Mr. Gampp served as the Executive
Vice President and Chief Operating Officer of Synergetics, Inc.
and had served in this position since Synergetics, Inc. was
founded in 1991. Mr. Gampp coordinates and supervises the
manufacturing of the Companys products and is in charge of
the daily production operations of the Company.
|
|
|
2008
|
|
Jerry L. Malis
|
|
|
75
|
|
|
Jerry L. Malis is the Companys Executive Vice President
and Chief Scientific Officer and has served in these positions
and as director since 2005. Immediately prior to the
consummation of the merger with Valley Forge, Mr. Malis
served as Valley Forges Chief Executive Officer, President
and Chairman of the board of Valley Forge. He has published over
50 articles in the biological science, electronics and
engineering fields, and has been issued ten United States
patents. Mr. Malis coordinates and supervises the
scientific developments of the Company.
|
|
|
2008
|
|
CORPORATE
GOVERNANCE
The Companys Board of Directors met six times during the
fiscal year ended July 31, 2007, two of which were special
meetings. Each of our directors attended at least 75% of all the
meetings of the Board and those committees on which he or she
served during fiscal year 2007. The Board of Directors
encourages all members to attend stockholder meetings, but has
not adopted a formal policy regarding attendance. Six directors
attended last years annual stockholder meeting.
Each of the directors other than Mssrs. Scheller, Gampp and
Malis satisfies the definition of an independent director set
forth in the listing standards of The NASDAQ Stock Market, Inc.
(Nasdaq) and the Companys Corporate Governance
Guidelines, available on the Companys website at
www.synergeticsusa.com.
The Companys Corporate Governance Guidelines also state
that the independent directors should meet each time that a
regularly scheduled Board meeting is held, in addition to
holding other meetings as needed. During fiscal 2007, the
independent directors held four meetings in conjunction with the
four regularly scheduled Board meetings.
The Board of Directors maintains three standing committees,
including an Audit Committee, a Compensation Committee and a
Nominating and Corporate Governance Committee. Each of these
committees operates pursuant to a written charter setting forth
the functions and responsibilities of the committee, which may
be reviewed on our website at www.synergeticsusa.com and
are also available to stockholders in print upon request.
Audit
Committee
The Audit Committee is responsible for the appointment,
evaluation, compensation and oversight of the work of the
independent registered public accountants and, where
appropriate, the dismissal of the independent registered public
accountants. Furthermore, the Audit Committee is responsible for
meeting with the independent registered public accountants and
other corporate officers to review matters relating to financial
reporting and accounting procedures and policies. Among other
responsibilities, the Audit Committee also reviews financial
information provided to stockholders and others, assesses the
adequacy of financial, accounting, operating and disclosure
controls, evaluates the scope of the audits of the independent
registered public accounting firm and internal auditors, and
reports on the results of such audits to the Board of Directors.
In addition, the Audit Committee assists the Board of Directors
in its oversight of the performance of the Companys
independent registered public accountants. The current members
of the Audit Committee are Ms. Hinshaw (Chairperson),
Mr. Dick, and Mr. Cardinale, all of whom meet all
applicable standards for Audit Committee membership under the
NASDAQ listing standards and Securities
4
and Exchange Commission (SEC) rules. The Board of
Directors has determined that Ms. Hinshaw qualifies as an
audit committee financial expert because she has served in
oversight roles in finance and accounting. The Audit Committee
held six meetings with two continuations during the last fiscal
year.
Compensation
Committee
The Compensation Committee is composed entirely of independent
directors, as defined by The Nasdaq Stock Market listing
standards and SEC rules, and is responsible for administering
the Companys compensation programs and recommending to the
Board of Directors other compensation and benefits of the Chief
Executive Officer and all named executive officers. The current
members of the Compensation Committee are Mr. Dick
(Chairperson), Mr. Cardinale and Mr. Guarch. The
Compensation Committee held six meetings during the last fiscal
year.
The Compensation Committee meets at the end of each fiscal year
to determine and recommend to the Board for approval the
compensation packages for executive officers in light of the
Companys compensation philosophy and objectives as
presented in the Compensation Discussion and
Analysis below. In making its recommendations, the
Compensation Committee considers input from the Chief Executive
Officer as to compensation for each executive officer based upon
their performance against Company and personal objectives, other
than himself. The Compensation Committee has full responsibility
to recommend to the independent directors of the Board the
compensation package of the Chief Executive Officer.
Nominating
and Corporate Governance Committee
The members of the Companys Nominating and Corporate
Governance Committee are Mr. Cardinale (Chairperson),
Mr. Dick and Mr. Guarch, all of whom meet the
independence requirements of The Nasdaq Stock Market listing
standards and SEC rules. The Nominating and Corporate Governance
Committee is responsible for identifying individuals qualified
to become members of the Board of Directors, recommending to the
Board of Directors the director nominees to be proposed for
election by the stockholders and recommending to the Board of
Directors corporate governance guidelines and procedures
applicable to the Company. The Nominating and Corporate
Governance Committee held one meeting during the last fiscal
year.
The Nominating and Corporate Governance Committee will consider
nominees recommended by stockholders of the Company. Each
stockholder must comply with applicable requirements of the
Companys Bylaws and the Exchange Act with respect to the
nomination of, or proposal of, nominees for election as
directors of the Company. Stockholders should submit any such
nominations, together with appropriate biographical information
and a description of the nominees qualifications to serve
as director, to the Chairperson of the Nominating and Corporate
Governance Committee,
c/o Pamela
G. Boone, Secretary, Synergetics USA, Inc., 3845 Corporate
Centre Drive, OFallon, Missouri, 63368. The Nominating and
Corporate Governance Committee has not established specific,
minimum qualifications for director nominees that it recommends
to the Board of Directors, but instead considers all factors it
deems relevant, including sound judgment, business
specialization, technical skills, diversity and the extent to
which the candidate would fill a present need. Nominees to be
evaluated by the Nominating and Corporate Governance Committee
for future vacancies on the Board of Directors will be selected
by the Committee from candidates recommended by multiple
sources, including members of the Board of Directors, senior
management, independent search firms, stockholders and other
sources, all of whom will be evaluated based on the same
criteria.
Code of
Conduct and Ethics
The Company has established a Code of Business Conduct and
Ethics, which is applicable to all of its employees, officers
and directors. The Code is available on the Companys
website at www.synergeticsusa.com and also available to
stockholders in print upon request. We intend to post any future
amendments and revisions to the Code of Business Conduct and
Ethics on our website.
5
COMPENSATION
COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION
All executive officer compensation decisions are made by the
Companys Compensation Committee. The Compensation
Committee also reviews and makes recommendations to the Board of
Directors regarding the compensation of all named executive
officers and other key employees, including salaries and
bonuses. As of July 31, 2007, the members of the
Compensation Committee for Synergetics USA, Inc. are
Mr. Robert H. Dick (Chairperson), Mr. Lawrence C.
Cardinale and Mr. Guy R. Guarch.
No member of the Compensation Committee of the Company during
fiscal 2007 was an employee or officer of the Company or any of
its subsidiaries. During the year ended July 31, 2007, no
executive officer of the Company served as a member of
(i) the compensation committee of another entity in which
one of the executive officers of such entity served on the
Companys Compensation Committee, (ii) the Board of
Directors of another entity in which one of the executive
officers of such entity served on the Companys
Compensation Committee, or (iii) the compensation committee
of another entity in which one of the executive officers of such
entity served as a member of the Companys Board of
Directors.
COMMUNICATIONS
WITH THE BOARD OF DIRECTORS
Stockholders may communicate directly with the Board of
Directors, as a group, or any individual director by submitting
written correspondence addressed to them at Synergetics USA,
Inc., 3845 Corporate Centre Drive, OFallon, Missouri,
63368.
DIRECTOR
COMPENSATION
Directors who are neither employees of the Company nor an
immediate family member of an officer of the Company are paid
$750 for each meeting of the Board of Directors and each meeting
of a committee of the Board of Directors that they attend. The
Chairperson of the Audit Committee receives $2,250 for each
meeting of the Audit Committee. In addition, all directors are
entitled to reimbursement for travel and lodging expenses
incurred in connection with their attendance at meetings.
Compensation for members of the Board has been established and
will be reviewed annually by the Compensation Committee. The
Compensation Committee may not delegate its authority regarding
director compensation, and no executive officer plays a role in
determining the amount of director compensation. The
Compensation Committee considers the amount of time directors
dedicate to Company matters and the need to attract and retain
qualified directors when determining Board compensation. For
example, the Compensation Committee has approved additional
compensation for the Audit Committee Chairperson in recognition
of the time commitment required by such position.
To align the interests of directors with those of the
Companys stockholders, each independent director also
receives an option to purchase 10,000 shares of the
Companys common stock each year in which he or she is
elected, appointed, or re-elected to serve as a director
pursuant to the 2005 Non-Employee Directors Stock Option
Plan.
The following table discloses compensation paid for the fiscal
year ended July 31, 2007 to the directors for serving as
members of the Board.
2007 Director
Compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fees Earned
|
|
|
|
|
|
|
|
|
|
or
|
|
|
Option
|
|
|
|
|
|
|
Paid in Cash
|
|
|
Awards
|
|
|
Total
|
|
Name
|
|
($)
|
|
|
($)(1)
|
|
|
($)
|
|
|
Lawrence C. Cardinale
|
|
$
|
15,750
|
|
|
$
|
29,800
|
|
|
$
|
45,550
|
|
Robert H. Dick
|
|
$
|
15,750
|
|
|
$
|
29,800
|
|
|
$
|
45,550
|
|
Guy R. Guarch
|
|
$
|
7,500
|
|
|
$
|
29,800
|
|
|
$
|
37,300
|
|
Juanita H. Hinshaw
|
|
$
|
21,750
|
|
|
$
|
29,800
|
|
|
$
|
51,550
|
|
6
|
|
|
(1) |
|
The fair value of options granted to the independent directors
during the fiscal year ended July 31, 2007 was determined
at the date of the grant using a Black-Scholes options-pricing
model and the following assumptions: |
|
|
|
|
|
Expected average risk-free interest rate
|
|
|
4.0
|
%
|
Expected average life (in years)
|
|
|
5.0
|
%
|
Expected volatility
|
|
|
79.7
|
%
|
Expected dividend yield
|
|
|
0.0
|
%
|
The fair value on the date of the grant was $2.98, the exercise
price is $3.89 and the options vest immediately and are
exercisable for ten years.
Mssrs. Scheller, Gampp and Malis receive no compensation for
their services as directors of the Company.
PRINCIPAL
STOCKHOLDERS
The following table sets forth as of November 7, 2007
certain information with respect to the beneficial ownership of
the Companys common stock by (i) each of the named
executive officers and directors, (ii) all executive
officers and directors as a group, and (iii) each person
known by the Company to beneficially own more than 5% of the
Companys common stock based on certain filings made under
Section 13 of the Exchange Act. All such information
provided by the stockholders who are not executive officers or
directors reflects their beneficial ownership as of the dates
specified in the footnotes to the table. The percent of shares
beneficially owned is based on 24,274,500 shares issued and
outstanding as of November 7, 2007.
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
Percent of
|
|
|
|
Synergetics USA
|
|
|
Shares
|
|
|
|
Shares Beneficially
|
|
|
Beneficially
|
|
Name and Address of Beneficial Owner
|
|
Owned
|
|
|
Owned
|
|
|
(i) Named Executive Officers and Directors(1)
|
|
|
|
|
|
|
|
|
Gregg D. Scheller(2),(3)
|
|
|
820,623
|
|
|
|
3.4
|
%
|
Lawrence C. Cardinale(2),(4)
|
|
|
34,244
|
|
|
|
*
|
|
Robert H. Dick(2),(5)
|
|
|
84,000
|
|
|
|
*
|
|
Kurt W. Gampp, Jr.(2),(6)
|
|
|
863,392
|
|
|
|
3.6
|
%
|
Guy R. Guarch(2),(7)
|
|
|
22,000
|
|
|
|
*
|
|
Juanita H. Hinshaw(2),(8)
|
|
|
336,710
|
|
|
|
1.4
|
%
|
Jerry L. Malis(2),(9)
|
|
|
1,114,745
|
|
|
|
4.6
|
%
|
Pamela G. Boone(2),(10)
|
|
|
47,437
|
|
|
|
*
|
|
(ii) All Executive Officers and Directors as a Group
(8 persons)
|
|
|
3,323,151
|
|
|
|
13.6
|
%
|
(iii) Certain Beneficial Owners
|
|
|
|
|
|
|
|
|
JPMorgan Chase & Co.
|
|
|
1,347,650
|
|
|
|
5.6
|
%
|
|
|
|
* |
|
Less than 1%. |
|
(1) |
|
Except as indicated in the footnotes to this table, the persons
named in the table have sole voting and investment power with
respect to all shares of common stock shown as beneficially
owned by them. |
|
(2) |
|
The mailing address of Messrs. Scheller, Cardinale, Dick,
Gampp, Guarch and Malis and Mses. Hinshaw and Boone is 3845
Corporate Centre Drive, OFallon, Missouri 63368. |
|
(3) |
|
Includes 809,373 shares held in the Gregg D. Scheller
Trust. Mr. Scheller, in his capacity as trustee, possesses
sole voting and investment power with respect to these shares.
Also includes 3,750 shares issuable to Mr. Scheller
subject to options exercisable currently or within 60 days.
This does not include 817,020 shares held by the Donna
Scheller Trust, of which Mr. Schellers wife is
trustee. Mr. Scheller disclaims beneficial ownership as to
these shares. |
|
(4) |
|
Includes 20,000 shares issuable to Mr. Cardinale
subject to options exercisable currently or within 60 days. |
|
(5) |
|
Includes 84,000 shares issuable to Mr. Dick subject to
options exercisable currently or within 60 days. |
7
|
|
|
(6) |
|
Includes shares held in the Kurt W. Gampp, Jr. Trust. This does
not include 106,725 shares held by the Julie Gampp Trust,
of which Mr. Gampps wife is trustee, nor
62 shares held by his daughter, Lindsey Gampp.
Mr. Gampp disclaims beneficial ownership as to these shares. |
|
(7) |
|
Includes 20,000 shares issuable to Mr. Guarch subject
to options exercisable currently or within 60 days. |
|
(8) |
|
Includes shares held in the Hinshaw-Harrison Joint Revocable
Living Trust. Ms. Hinshaw, in her capacity as trustee,
possesses joint voting and investment power with respect to
these shares. Also includes 20,000 shares issuable to
Ms. Hinshaw subject to options exercisable currently or
within 60 days. |
|
(9) |
|
Includes 50,000 shares issuable to Mr. Malis subject
to options exercisable currently or within 60 days. Also
includes 200,000 shares held in the Malis Family L.P., a
limited partnership in which Jerry L. Malis is the general
partner and possesses voting and investment power. |
|
(10) |
|
Includes 17,437 shares issued to Ms. Boone subject to
restrictions including a cliff vesting period of five years from
the date of the grant in March, 2006 and August, 2007. |
|
(11) |
|
Pursuant to JPMorgan Chase & Co. Schedule 13G
filed with the Securities and Exchange Commission on
December 29, 2006, JPMorgan Chase & Co. has the
sole power to vote 1,200,650 shares and the sole
dispositive power over 1,347,650 shares. The address of
JPMorgan Chase & Co. is 270 Park Avenue,
New York, NY 10017. |
COMPLIANCE
WITH SECTION 16(a) OF THE SECURITIES AND EXCHANGE
ACT
Section 16(a) of the Exchange Act requires the
Companys directors and executive officers, and persons who
own more than 10% of a registered class of the Companys
equity securities, to file reports of ownership of, and
transactions in, the Companys securities with the SEC and
The NASDAQ Stock Market. Such directors, executive officers and
10% stockholders are also required to furnish the Company with
copies of all Section 16(a) forms they file.
Based solely upon a review of reports furnished to the Company,
and on written representations from certain reporting persons,
the Company believes that, with respect to the fiscal year ended
July 31, 2007, each director, executive officer and 10%
stockholder of the Companys securities made timely filings
of all reports required by Section 16 of the Exchange Act,
except as follows: Messrs. Cardinale and Guarch each filed
a late Form 4 reporting their grants of stock options
pursuant to the 2005 Non-Employee Directors Stock Option
Plan (Mr. Cardinales Form 4 was filed on
November 7, 2007 for awards granted on November 30,
2006; and Mr. Guarchs Form 4 was filed on
November 7, 2007 for awards granted on November 30,
2006). Mr. Scheller filed a late Form 4 on
June 14, 2007 for awards granted on March 30, 2007.
Ms. Boone filed a late Form 4 on November 6, 2007
reporting her grant of restricted stock options on
August 1, 2007.
EXECUTIVE
OFFICERS
The following table sets forth certain information, as of the
date of this proxy statement, with respect to the executive
officers of the Company.
|
|
|
|
|
|
|
Name
|
|
Age
|
|
Position(s) with the Company
|
Gregg D. Scheller
|
|
|
52
|
|
|
President, Chief Executive Officer & Chairman of the Board
of Directors
|
Kurt W. Gampp, Jr.
|
|
|
47
|
|
|
Executive Vice President, Chief Operating Officer & Director
|
Jerry L. Malis
|
|
|
75
|
|
|
Executive Vice President, Chief Scientific Officer &
Director
|
Pamela G. Boone
|
|
|
44
|
|
|
Executive Vice President, Chief Financial Officer, Treasurer
& Secretary
|
The biographical information for Messrs. Scheller, Gampp
and Malis can be found under Proposal 1
Election of Directors above.
8
Ms. Boone joined the Company as its Chief Financial Officer
in May 2005. Prior to this, Ms. Boone served as Vice
President and Chief Financial Officer of Maverick Tube
Corporation from 2001 until January 2005 and as Vice President,
Treasurer and acting Chief Financial Officer until May 2005.
Maverick Tube Corporation, a Missouri-based company, was a
leading North American producer of welded tubular steel products
used in energy and industrial applications. From 1997 to 2001,
Ms. Boone served as Mavericks Corporate Controller.
Compensation
Discussion and Analysis
The following Compensation Discussion and Analysis describes the
material elements of compensation for our named executive
officers.
Executive
Compensation Philosophy and Objectives
The Compensation Committee believes that compensation paid to
our named executive officers should accomplish the following
objectives:
|
|
|
|
|
Reflect the accomplishment of corporate and individual
objectives, and
|
|
|
|
Assist the Company in attracting, motivating and retaining
superior talent.
|
Our compensation program is intended to motivate our named
executive officers to achieve our business objectives and to
align their financial interests with those of our stockholders.
These objectives are furthered by a compensation philosophy that
is based on the following:
|
|
|
|
|
Accountability and Recognition for Individual and Corporate
Performance: Compensation should depend, in part,
on the Companys overall performance and on each executive
officers performance in order to motivate and reward
success. The Compensation Committee has provided for a portion
of the overall compensation packages to be tied to performance
through the payments of short-term incentive awards in the form
of cash bonuses and the grant of long-term incentive awards in
the form of stock options and restricted stock.
|
|
|
|
Competition with the Market: Base salaries
should generally be competitive with officers with similar
positions at companies within our industry and market, subject
to individual adjustments as discussed below.
|
Compensation
Determination Process
Our Compensation Committee is responsible for establishing,
implementing and monitoring our executive compensation program.
The Compensation Committee consists of Messrs. Dick,
Cardinale and Guarch, each of whom is an independent director.
The Compensation Committee typically meets following each fiscal
year end to (i) consider and approve salary changes and
annual incentive bonuses, if any; (ii) determine and
approve long-term incentive awards, if any; and
(iii) establish goals for the annual incentive program.
In making its determinations regarding compensation, the
Compensation Committee evaluates corporate performance and each
executive officers individual performance. In addition,
although the Company does not engage in any formal benchmarking,
the Compensation Committee does review compensation data from
the following companies (collectively, the Peer
Companies):
|
|
|
|
|
SteroTaxis, Inc. a public medical devices company in the
St. Louis, Missouri area;
|
|
|
|
Escalon Medical Corp., Inspire Pharmaceuticals Inc., Iridex
Corporation and Staar Surgical Company (each of which the
Company believes to be a peer in the ophthalmic
industry), and
|
|
|
|
Bovie Medical Corporation, Possis Medical, Inc. and Vascular
Solutions, Inc. (each of which is a participant in the
Companys general industry and each of which has revenues
of less than $100 million).
|
The Compensation Committee reviews the executive officer
compensation packages at the Peer Companies in connection with
its executive officer compensation determinations. Although the
Compensation Committee does not formally benchmark against the
Peer Companies, or target a median or other point for the
executive officer
9
compensation packages, it does utilize the Peer Companies
compensation data for purposes of setting executive officer
compensation.
The mix of the Companys cash and non-cash compensation and
short- and long-term compensation is not subject to a specific
policy. Instead, the Compensation Committee considers the Peer
Companies compensation data in light of the Companys
compensation philosophies and objectives outlined above, as well
as corporate and individual performance, and makes gradual
changes over time as necessary to further these compensation
goals. The Chief Executive Officer makes recommendations to the
Compensation Committee regarding proposed salary changes,
bonuses and equity compensation awards, if any, for each
executive officer other than the Chief Executive Officer. The
Chief Executive Officer also assists the Compensation Committee
in setting Company performance goals on which part of each
officers total compensation is based. The Compensation
Committee considers this input from the Chief Executive Officer,
as well as other factors it believes are relevant, and
determines the compensation packages of the executive officers,
including the Chief Executive Officer.
Elements
of Compensation
Base Salary. The base salaries of each of
Messrs. Scheller, Gampp and Malis and Ms. Boone in
fiscal 2007 were established in employment terms negotiated with
each of these officers at the time of the merger of Synergetics,
Inc. and Valley Forge, before the current Compensation Committee
of the Board of Directors of the Company had been formed. The
employment agreements with Messrs. Scheller, Gampp and
Malis were entered into in September 2005 in anticipation of the
completion of the merger and provide for minimum base salaries
of $377,000, $346,000 and $230,000, respectively. Ms. Boone
joined the Company in May 2005, and her employment terms
provided for a minimum base salary of $175,000.
Ms. Boones 2007 salary was increased to $200,000 by
the Compensation Committee based on Ms. Boones
contributions to the successful merger and transition of
Synergetics, Inc. to a public company.
For fiscal 2008, the Compensation Committee reviewed and
recommended to the full Board of Directors base salary increases
for the named executive officers. Ms. Boones salary
increase was reflected in the minimum base salary established in
her employment agreement entered into in August 2007. These
salary increases were based on the Companys desires that
base salaries remain competitive to attract, retain and motivate
named executive officers as well as reward performance.
When evaluating competitiveness, the Compensation Committee
evaluates the salaries of officers with similar positions at the
Peer Companies. As noted above, in reviewing comparative data,
the Compensation Committee does not engage in benchmarking for
the purpose of establishing salary levels relative to any
predetermined point. In the Compensation Committees view,
this external data provides insight into competitiveness, but is
not an appropriate single factor in determining base salaries.
Rather, the Compensation Committee, as noted above, takes into
account overall performance of the named executive officers and
the Company.
The Compensation Committee bases salary increases on a
combination of Company and individual performance. Company
performance is based on the achievement of the Companys
goals as set forth in its annual financial plan, which is
discussed in further detail below. The Compensation Committee
has not established specific individual performance criteria for
purposes of determining salary increases, but bases its
decisions on its evaluation of (i) each named executive
officers general performance over the prior fiscal year,
taking into consideration the accomplishment scores each
receive, as more fully described below; (ii) the scope of
each officers duties and responsibilities; and
(iii) each officers experience and expertise. The
Compensation Committee seeks input from Mr. Scheller in
evaluating the named executive officers other than himself.
10
Based on the factors discussed above, the Compensation Committee
increased the base salaries for the named executive officers for
fiscal 2008 as illustrated in the table below:
|
|
|
|
|
|
|
|
|
|
|
Fiscal 2008
|
|
|
|
|
|
|
Percentage Salary
|
|
|
|
|
Name
|
|
Increase
|
|
|
Fiscal 2008 Salary
|
|
|
Gregg D. Scheller
|
|
|
5
|
%
|
|
$
|
395,850
|
|
Kurt W. Gampp, Jr.
|
|
|
4
|
%
|
|
$
|
359,840
|
|
Jerry L. Malis
|
|
|
4
|
%
|
|
$
|
240,240
|
|
Pamela G. Boone
|
|
|
16
|
%
|
|
$
|
232,000
|
|
Bonus Compensation. Prior to fiscal 2007,
bonuses to executive officers were discretionary, based on the
Compensation Committees evaluation of each executive
officers individual performance and the Companys
overall performance. Determinations regarding bonuses were based
on qualitative criteria, including the achievement of sales
forecasts and successful transition after Synergetics,
Inc.s merger with Valley Forge and compliance with public
company reporting requirements. The Compensation Committee and
Company management believe the establishment of clear objectives
with periodic measurement of results is an effective method for
focusing resources, communicating mission and strategy for the
period, and in determining the individual managers
contribution to the achievement of Company goals. Accordingly,
beginning in fiscal 2007, the Company implemented a method for
establishing clear, measurable objectives for the named
executive officers, divided into three categories:
|
|
|
|
|
Company-wide objectives,
|
|
|
|
Functional objectives, and
|
|
|
|
Personal development objectives.
|
The objectives of each category are a function of the
individuals responsibilities and span of control. For the
named executive officers, Company-wide objectives are weighed
more heavily than functional and personal development objectives
in evaluating performance. The Compensation Committee is
involved in the establishment and approval of the Company-wide
objectives, as well as functional and personal objectives for
the executive officers and seeks the input of the Chief
Executive Officer in determining these objectives for named
executive officers other than himself. In addition, the Chief
Financial Officer assists the Compensation Committee in
determining Company-wide financial objectives.
Company-wide objectives established for fiscal 2007 include for
the named executive officers: earnings per share, net income,
gross profit and sales. The Committee considers these goals to
be confidential, the disclosure of which would cause the Company
competitive harm. These goals are set at aggressive levels each
year to motivate the named executive officers to succeed and
focus on both short and long-term Company objectives. Target
goals are designed to be challenging and as such, the Committee
believes that the Companys target performance would not be
achieved all of the time, but that the payout relating to these
goals should be appropriate for the performance, regardless of
how often target levels are reached.
In addition, each named executive officer has both functional
and personal developmental goals which include projects within
their functional areas of the Company and individual growth
goals unrelated to financial or project goals.
11
Accomplishments at the end of the period are compared to
objectives set at the beginning of the period with
scoring of each objective relative to 100%
accomplishment of the objective. The scores for each category
are then averaged, and the average score is translated to a
percentage of base salary in accordance with the following scale:
|
|
|
|
|
Average
|
|
|
Accomplishment
|
|
Percent of
|
Score
|
|
Base Salary
|
|
96%
|
|
|
1
|
%
|
97%
|
|
|
2
|
%
|
98%
|
|
|
3
|
%
|
99%
|
|
|
4
|
%
|
100%
|
|
|
5
|
%
|
101%
|
|
|
7
|
%
|
102%
|
|
|
9
|
%
|
103%
|
|
|
11
|
%
|
104%
|
|
|
13
|
%
|
105%
|
|
|
15
|
%
|
106%-115%
|
|
|
20
|
%
|
116%-125%
|
|
|
25
|
%
|
For the named executive officers, the accomplishment scores are
also considered generally in compensation decisions for base
salary adjustments and equity award grants, if any.
The Compensation Committee has not yet made any determinations
regarding executive officer incentive bonuses for the fiscal
year ended July 31, 2007, as it is still reviewing the
financial performance of the Company during fiscal 2007. The
Company intends to disclose these annual incentive bonuses on a
Form 8-K
once they are determined. In addition to any incentive bonuses
which may be awarded, each executive officer was awarded a
$5,000 non-incentive, non-discretionary holiday bonus during
fiscal 2007, which are reflected in the Summary Compensation
Table.
In fiscal 2007, the Company recorded compensation expense for
bonuses awarded in the form of vacations, or the cash equivalent
thereof, to each of Messrs. Gampp and Malis and
Ms. Boone. In lieu of his vacation, Mr. Scheller
received his bonus in fiscal 2007 in the form of options to
purchase 15,000 shares of common stock pursuant to the
Companys Amended and Restated 2001 Stock Plan (the
2001 Plan). Each of these bonuses was awarded based
on the accomplishment of the executive officers 2006
objectives related to the post-merger transition, fulfillment of
post-merger public company duties and responsibilities and
achievement of the Companys sales forecast. The cash
equivalent of the bonus vacations, in addition to the
gross-up on
taxes reimbursed for such vacations, are included in the All
Other Compensation column of the Summary Compensation Table.
Equity Awards. Equity compensation is
currently not a major component of the Companys executive
compensation program. Rather, the Compensation Committee grants
equity-based compensation pursuant to established employment
terms, in the case of Ms. Boone, or for exceptional
performance that for fiscal 2007 will be based on the
accomplishment scores described above. The Compensation
Committee has not yet determined the equity incentive awards, if
any, based on fiscal 2007 performance, as it is reviewing the
performance of the Company during fiscal 2007 in light of its
Company-wide objectives. However, the Compensation Committee did
award Ms. Boone 11,050 shares of restricted stock in
August 2007 pursuant to her negotiated employment terms.
During fiscal 2007, Mr. Scheller received options to
purchase 15,000 shares of common stock as his annual bonus,
in lieu of a bonus vacation. The exercise price of these options
is $3.58 per share, which was the closing price on
March 30, 2007, the date of grant. The options vest in four
equal installments on June 30, September 30, December
30 and March 30, 2008 and have a ten-year term.
Both Mr. Schellers options and Ms. Boones
restricted common stock were granted under our 2001 Plan.
Furthermore, any equity awards, if any, to be made based on
fiscal 2007 performance will be made under the 2001 Plan.
Pursuant to the 2001 Plan, employees, including our executive
officers, of, and consultants and advisors to, our
12
Company and its subsidiaries are eligible to receive awards of
incentive and non-statutory stock options, restricted stock and
unrestricted common stock. The Compensation Committee has the
exclusive authority and sole discretion to administer the 2001
Plan, including the power to determine eligibility, the types
and sizes of awards, the price and timing of awards and the
acceleration or waiver of any vesting restriction, subject to
the limitations set forth in the 2001 Plan.
Pursuant to the terms of the 2001 Plan, stock options with
respect to no more than 100,000 shares of common stock may
be granted to any individual participant during any one calendar
year period. Options granted pursuant to the 2001 Plan are
subject to the terms of the option agreement related to the
specific grant; provided, however, that (i) the term
of any incentive stock option granted to a non-10% stockholder
of the Company pursuant to the 2001 Plan may be no more than
10 years from the date of grant, and (ii) the term of
any incentive stock option granted to a 10% stockholder of the
Company pursuant to the 2001 Plan may be no more than five years
from the date of grant.
Incentive stock options must be granted at no less than the fair
market value of the Companys common stock on the grant
date; provided, however, that incentive stock options
granted to 10% stockholders must be granted at no less than 110%
of such fair market value. Non-statutory stock options must be
granted at no less than 85% of the fair market value of the
Companys common stock on the date of grant.
To the extent that an optionees employment with the
Company is terminated other than for cause, the optionee may,
but only within 90 days (or such other period of time as
determined by the Board of Directors) after such date of
termination, but in no event later than the expiration date of
the option as set forth in the respective option agreement,
exercise his or her options to the extent the optionee was
entitled to exercise the option at the date of termination.
Pursuant to the terms of the 2001 Plan, restricted stock awards
may also be granted. Restricted stock awards are subject to such
restrictions and conditions as the Compensation Committee
determines. Such conditions may be based on continuing
employment
and/or
achievement of pre-established performance goals and objectives.
If the recipient violates any of the restrictions during the
period specified by the committee or the performance standards
fail to be satisfied, the restricted stock is forfeited.
Other Employment Benefits. Synergetics
named executive officers are provided with a limited number of
perquisites. In fiscal 2007, he Company provided the following:
|
|
|
|
|
Reimbursements for taxes paid on reimbursed travel expenses
considered as income in connection with the award of the fiscal
2007 bonus vacations; and
|
|
|
|
Automobile allowance with respect to Mr. Malis.
|
Severance and Other Post-Termination
Benefits. Each of our named executive officers
has an employment agreement with the Company. These employment
agreements provide for certain payments upon termination,
depending on the circumstances of termination. In the case of
Ms. Boone, her agreement also provides for certain payments
upon a change of control. These provisions are discussed later
in this proxy statement.
Impact
of Tax Treatments of Executive Compensation
Section 162(m) of the Internal Revenue Code of 1986, as
amended, provides that compensation in excess of $1,000,000 paid
to the Chief Executive Officer or to any of the other four most
highly compensated executive officers of a publicly held
corporation will not be deductible for federal income tax
purposes unless such compensation is paid pursuant to one of the
enumerated exceptions set forth in Section 162(m). In
general, stock options granted under our 2001 Equity Incentive
Plan are intended to qualify under and comply with the
performance based compensation exemption provided
under Section 162(m), thus excluding from the
Section 162(m) compensation limitation any income
recognized by executives pursuant to such stock options. In
fiscal 2007, no executive officer received compensation that
triggered the applicability of Section 162(m). The
Compensation Committee intends to review periodically the
potential impacts of Section 162(m) in structuring and
administering our compensation programs.
13
Report of
Compensation Committee
The Companys Compensation Committee has reviewed and
discussed the Compensation Discussion and Analysis with
management and, based on such review and discussions, the
Compensation Committee recommended to the Companys Board
of Directors that the Compensation Discussion and Analysis be
included in this Proxy Statement on Schedule 14A and
incorporated by reference in the Companys Annual Report on
Form 10-K
for the fiscal year ended July 31, 2007.
Submitted by the Compensation Committee of the Board of
Directors.
Robert H. Dick (Chairperson)
Lawrence C. Cardinale
Guy R. Guarch
2007
Summary Compensation Table
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted
|
|
|
|
|
|
All
|
|
|
|
|
Name and Principal
|
|
|
|
|
|
|
|
|
|
|
Stock
|
|
|
Option
|
|
|
Other
|
|
|
|
|
Position
|
|
Fiscal Year
|
|
|
Salary
|
|
|
Bonus
|
|
|
Awards
|
|
|
Awards
|
|
|
Compensation
|
|
|
Total
|
|
|
Gregg D. Scheller
|
|
|
2007
|
|
|
$
|
377,000
|
|
|
$
|
5,000
|
|
|
|
|
|
|
$
|
14,850
|
(2)
|
|
|
|
|
|
$
|
396,850
|
|
President and Chief
Executive Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Kurt W. Gampp, Jr.
|
|
|
2007
|
|
|
$
|
346,000
|
|
|
$
|
5,000
|
|
|
|
|
|
|
|
|
|
|
$
|
23,248
|
(5)
|
|
$
|
374,248
|
|
Executive Vice
President & Chief
Operating Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Jerry L. Malis
|
|
|
2007
|
|
|
$
|
231,000
|
|
|
$
|
5,000
|
|
|
|
|
|
|
|
|
|
|
$
|
21,794
|
(4)(5)
|
|
$
|
257,794
|
|
Executive Vice
President & Chief
Scientific Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pamela G. Boone
|
|
|
2007
|
|
|
$
|
200,000
|
|
|
$
|
5,000
|
|
|
$
|
7,000
|
(1)
|
|
$
|
7,518
|
(3)
|
|
$
|
12,994
|
(5)
|
|
$
|
232,512
|
|
Executive Vice
President & Chief
Financial Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The restricted stock holdings of Ms. Boone were
6,387 shares granted on March 7, 2006 at $5.48 per
share. The restricted stock will vest 100% on March 7,
2011. Dividends will be paid on this restricted stock if the
Company grants dividends to its common stockholders. |
|
(2) |
|
The option holdings of Mr. Scheller were 15,000 options
granted on March 30, 2007 at $3.58 per share. The options
will vest 25% on June 30, 2007, 25% on September 30,
2007, 25% on December 30, 2007 and 25% on March 30,
2008. |
|
(3) |
|
The option holdings of Ms. Boone were 41,310 options
granted on May 19, 2005 at $1.09 per share. The options
will vest 50% on May 19, 2009 and 50% on May 19, 2010. |
|
(4) |
|
All other compensation for Mr. Malis includes lease
payments on his automobile. |
|
(5) |
|
In fiscal 2007, the Company recorded compensation expense as
well as the tax
gross-up for
bonus trips awarded to Mr. Gampp, Mr. Malis, and
Ms. Boone for the accomplishments of their 2006 objectives
as the measurement of these accomplishments could not be
completed until fiscal 2007, as discussed in Compensation
Discussion and Analysis. |
14
2007
Grants of Plan Based Awards Table
The following table sets forth additional information about
plan-based awards granted in the fiscal year ended July 31,
2007.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All Other
|
|
|
All Other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Awards;
|
|
|
Option Awards;
|
|
|
|
|
|
Grant Date
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
Number of
|
|
|
Exercise or
|
|
|
Fair Value of
|
|
|
|
|
|
|
Estimated Future Payouts under
|
|
|
Shares of
|
|
|
Securities
|
|
|
Base Price of
|
|
|
Stock and
|
|
|
|
|
|
|
Equity Incentive Plan Awards
|
|
|
Stock or
|
|
|
Underlying
|
|
|
Option
|
|
|
Option
|
|
Name
|
|
Grant Date
|
|
|
Threshold
|
|
|
Target
|
|
|
Maximum
|
|
|
Units
|
|
|
Options
|
|
|
Awards
|
|
|
Awards
|
|
|
Gregg D. Scheller
|
|
|
3/30/07
|
|
|
|
|
|
|
|
15,000
|
(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
3.58
|
|
|
$
|
44,550
|
|
|
|
|
(1) |
|
The option holdings of Mr. Scheller were 15,000 options
granted on March 30, 2007 at $3.58 per share. The options
will vest 25% on June 30, 2007, 25% on September 30,
2007, 25% on December 30, 2007 and 25% on March 30,
2008. |
2007
Outstanding Equity Awards at Fiscal Year-End
The following table sets forth information on outstanding
options and stock awards held by the named executive officers as
of July 31, 2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option Awards
|
|
Stock Awards
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity
|
|
|
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive
|
|
|
Incentive
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Plan
|
|
|
Plan
|
|
|
|
|
|
|
|
|
|
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Awards:
|
|
|
Awards: Market
|
|
|
|
|
|
|
|
|
|
Incentive
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
or Payout
|
|
|
|
|
|
|
|
|
|
Plan
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unearned
|
|
|
Value of
|
|
|
|
|
|
|
|
|
|
Awards:
|
|
|
|
|
|
|
|
|
|
|
Market
|
|
|
Shares,
|
|
|
Unearned
|
|
|
|
Number of
|
|
|
Number of
|
|
|
Number
|
|
|
|
|
|
|
|
Number of
|
|
|
Value of
|
|
|
Units or
|
|
|
Shares,
|
|
|
|
Securities
|
|
|
Securities
|
|
|
of Securities
|
|
|
|
|
|
|
|
Shares or
|
|
|
Shares or
|
|
|
Other
|
|
|
Units or
|
|
|
|
Underlying
|
|
|
Underlying
|
|
|
Underlying
|
|
|
|
|
|
|
|
Units of
|
|
|
Units of
|
|
|
Rights
|
|
|
Other
|
|
|
|
Unexercised
|
|
|
Unexercised
|
|
|
Unexercised
|
|
|
Option
|
|
|
|
|
Stock That
|
|
|
Stock That
|
|
|
That Have
|
|
|
Rights
|
|
|
|
Options
|
|
|
Options
|
|
|
Unearned
|
|
|
Exercise
|
|
|
Option
|
|
Have Not
|
|
|
Have Not
|
|
|
Not
|
|
|
That Have
|
|
|
|
(#)
|
|
|
(#)
|
|
|
Options
|
|
|
Price
|
|
|
Expiration
|
|
Vested
|
|
|
Vested
|
|
|
Vested
|
|
|
Not Vested
|
|
Name
|
|
Exercisable
|
|
|
Unexercisable
|
|
|
(#)
|
|
|
($)
|
|
|
Date
|
|
(#)
|
|
|
($)
|
|
|
(#)
|
|
|
($)
|
|
|
Gregg D. Scheller
|
|
|
3,750
|
(1)
|
|
|
11,250
|
(1)
|
|
|
|
|
|
$
|
3.58
|
|
|
March 30,
2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Jerry L. Malis
|
|
|
50,000
|
(2)
|
|
|
|
|
|
|
|
|
|
$
|
1.125
|
|
|
December 12,
2010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pamela G. Boone
|
|
|
|
|
|
|
41,310
|
(3)
|
|
|
|
|
|
$
|
1.089
|
|
|
May 19,
2015
|
|
|
|
|
|
|
|
|
|
|
6,387
|
(4)
|
|
$
|
23,057
|
|
|
|
|
(1) |
|
The option holdings of Mr. Scheller were 15,000 options
granted on March 30, 2007 at an exercise price of $3.58 per
share. The options will vest 25% on June 30, 2007, 25% on
September 30, 2007, 25% on December 30, 2007 and 25%
on March 30, 2008. |
|
(2) |
|
The option holdings of Dr. Malis were 50,000 options
granted on December 12, 2000 at an exercise price of $1.125
per share and expire on December 12, 2010. All of these
options are exercisable at July 31, 2006. |
|
(3) |
|
The option holdings of Ms. Boone were 41,310 options
granted on May 19, 2005 at an exercise price of $1.09 per
share. The options will vest 50% on May 19, 2009 and 50% on
May 19, 2010. |
|
(4) |
|
The restricted stock holdings of Ms. Boone were
6,387 shares granted on March 7, 2006 at $5.48 per
share. The restricted stock will vest 100% on March 7,
2011. Dividends will be paid on this restricted stock if the
Company grants dividends to its common stockholders. |
Mr. Gampp did not have any options nor restricted stock
awards to purchase Synergetics USA common stock as of
July 31, 2007.
15
2007
Option Exercises and Stock Vested
The following table sets forth the exercise of stock options and
vesting of stock during fiscal 2007 for the named executive
officers.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option Awards
|
|
|
Stock Awards
|
|
|
|
Number of
|
|
|
|
|
|
Number of
|
|
|
|
|
|
|
Shares Acquired
|
|
|
Value Realized on
|
|
|
Shares Acquired
|
|
|
Value Realized
|
|
|
|
on Exercise
|
|
|
Exercise
|
|
|
on Vesting
|
|
|
on Vesting
|
|
Name
|
|
(#)
|
|
|
($)
|
|
|
(#)
|
|
|
($)
|
|
|
Gregg D. Scheller
|
|
|
|
|
|
|
|
|
|
|
3,750
|
|
|
$
|
13,088
|
|
EMPLOYMENT
AGREEMENTS AND SEVERANCE AGREEMENTS
Each of Messrs. Scheller, Malis, Gampp and Ms. Boone
has entered into three-year employment agreements with the
Company. Pursuant to the agreements, Mr. Schellers
base salary is $377,000, Mr. Malis base salary is
$230,000, Mr. Gampps base salary is $346,000 and
Ms. Boones base salary is $232,000. In addition, each
of them shall receive such other benefits, including healthcare,
dental, life insurance, disability and 30 days of paid
vacation that the Company provides to its executive officers.
Each of Messrs. Scheller, Malis and Gampp and
Ms. Boone may receive an annual bonus as determined in the
sole discretion of the Compensation Committee of the
Companys Board of Directors.
In the event any of Messrs. Scheller, Malis and Gampp is
terminated without cause, or if any such executive officer
resigns for good reason, such executive officer shall be
entitled to his base salary and health care benefits through the
end of the term of his employment agreement. If Ms. Boone
is terminated without cause or within twelve months following a
change of control, or if she resigns for good reason, she shall
be entitled to her base salary and health care benefits for a
15-month
period following termination.
As used in the employment agreements with Messrs. Scheller,
Malis and Gampp and Ms. Boone, cause means
(1) the executive officers conviction of any felony,
or conviction for embezzlement or misappropriation of Company
money or other property; (2) any act of gross negligence in
performing the executive officers duties; (3) the
executive officers willful refusal to execute his or her
duties (other than for disability); or (4) the executive
officers breach of the non-competition terms contained in
his employment agreement. Termination for the events described
in clauses (2) and (3) above will not constitute
termination for cause unless the executive officer
is provided written notice reasonably detailing such occurrence
and is given five business days after receipt of such notice to
cure such event and an opportunity to be heard before the
Companys Board of Directors.
As used in the employment agreements with Messrs. Scheller,
Malis and Gampp and Ms. Boone, the term good
reason means (1) failure to pay, or a reduction, by
the Company of the executive officers base salary;
(2) the failure or refusal by the Company to provide the
executive officer with the benefits set forth in his or her
employment agreement; (3) the assignment to the executive
officer of any duties materially inconsistent with the duties
set forth in the employment agreement, which assignment is not
cured within five business days of written notice to the
Company; (4) in the case of Mr. Malis, a requirement
imposed by the Company on Mr. Malis that results in
Mr. Malis being based at a location that is outside a
35-mile
radius of Valley Forges former corporate offices in
suburban Philadelphia, Pennsylvania, and in the case of
Messrs. Scheller and Gampp and Ms. Boone,
35 miles from the Companys current corporate offices
in OFallon, Missouri; (5) a change in the executive
officers title; (6) in the case of
Messrs. Scheller, Malis and Gampp, if the executive officer
is no longer a member of the Companys Board of Directors,
other than by death, disability or a removal by a shareholder
vote for cause; (7) any material breach by the Company of
the employment agreement, which breach is not cured within five
business days after receipt of written notice from the executive
officer; or (8) the termination of the executive
officers employment other than for cause, death or
disability.
As used in Ms. Boones employment agreement, a change
of control means a change in the ownership or effective control
of the Company, or a change in the ownership of a substantial
portion of the ownership of a substantial portion of the Company.
16
The employment agreements for each of Messrs. Scheller,
Malis and Gampp and Ms. Boone contain non-competition
provisions, depending on the circumstances of any termination of
employment, and non-solicitation provisions. Furthermore, each
of them has agreed that any products, inventions, discoveries
and improvements made by him during the employment term shall be
the property of the Company.
POST-TERMINATION
PAYMENTS
As noted above, the employment agreements for all named
executive officers contain provisions providing for certain
payments to the officers upon termination of their employment
without cause or their resignation for good reason.
Ms. Boones employment agreement also states that she
shall receive payments if her employment is terminated within
12 months of a change of control, but that no payments upon
termination or resignation as described above shall be received
upon her breach of the non-competition and non-solicitation
provisions of her employment agreement. Furthermore, if any of
the named executive officers employment is terminated upon
a change of control, all options to purchase common stock and
all restricted stock shall vest.
Assuming that the triggering event for post-termination payments
occurred on the last business day of the Companys fiscal
2007, the named executive officers would receive the following
payments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock
|
|
|
|
|
Named Executive Officer
|
|
Salary
|
|
|
Compensation
|
|
|
Total
|
|
|
Gregg D. Scheller(1)
|
|
$
|
450,830
|
|
|
$
|
1,125
|
|
|
$
|
451,955
|
|
Kurt W. Gampp, Jr.(1)
|
|
$
|
409,818
|
|
|
|
|
|
|
$
|
409,818
|
|
Jerry Malis(1)
|
|
$
|
273,607
|
|
|
|
|
|
|
$
|
273,607
|
|
Pamela G. Boone(2)
|
|
$
|
|
|
|
$
|
130,538
|
|
|
$
|
130,538
|
|
|
|
|
(1) |
|
The salary calculation includes 13 and 2/3 months of salary
for the period from August 1, 2007 through
September 21, 2008, which represents the remainder of the
employment agreements. |
|
(2) |
|
As of the last business day of fiscal 2007, Ms. Boone
employment agreement was not effective. In addition,
11,050 shares of restricted stock had not yet been awarded. |
CERTAIN
RELATIONSHIPS AND RELATED TRANSACTIONS
Since the late 1960s, the late Dr. Leonard Malis, one
of Valley Forges former directors, on an individual basis
has been a party to consulting and other agreements with
Codman & Shurtleff, Inc., the Companys principal
customer. Since 1983, Dr. Leonard Malis has been a party to
an agreement with Codman under which Dr. Leonard Malis
received royalty payments for the use of the
Malis®
trademark on certain products sold by Codman to end users,
including products Valley Forge sold to Codman. Dr. Leonard
Malis developed passive hand instruments for Codman with no
pecuniary benefits to Valley Forge. On October 22, 2004,
Valley Forge entered into an option agreement with
Dr. Leonard Malis under which Valley Forge was granted an
option to acquire the
Malis®
trademark from Dr. Leonard Malis at any time over a period
of five years.
On October 12, 2005, the Company exercised its option with
respect to the
Malis®
trademark. We paid the estate of Dr. Leonard I. Malis
$159,904 in cash and the remainder in a $3,997,600 promissory
note which will be paid in 25 equal quarterly installments of
$159,904. The Company has made four quarterly payments on this
note during the year ended July 31, 2007 and three
quarterly payments on this note during the year ended
July 31, 2006. The promissory note is secured by a security
interest in the trademark and our
DualWavetm
patents.
To identify and address any concerns regarding related party
transactions and ensure their proper disclosure, the Company
requires such transactions to be reported in its questionnaires
distributed to directors and officers each year and mandates
that all employees and directors report to a manager, supervisor
or other appropriate personnel all transactions presenting
potential conflicts of interest pursuant to its Code of Business
Conduct & Ethics. It is the policy that the
Companys Audit Committee review and approve all material
related party transactions, as defined in Item 404 of
Regulation S-K.
17
PROPOSAL 2
RATIFICATION OF INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM
Before Synergetics, Inc.s merger with Valley Forge,
completed on September 21, 2005, Rotenberg Meril Solomon
Bertiger & Guttilla, P.C.
(RMSB&G) was retained by Valley Forge to serve
as its independent registered public accounting firm, after the
resignation of Samuel Klein and Company on January 20,
2005. Prior to the consummation of the merger, Synergetics, Inc.
retained the services of McGladrey & Pullen, LLP
(McGladrey) to audit its financial statements for
inclusion in Valley Forges registration statement on
Form S-4
filed in connection with the merger.
On October 20, 2005, the Companys Audit Committee
terminated RMSB&Gs appointment as the Companys
independent registered public accounting firm. During
RMSB&Gs engagement, RMSB&G did not report on the
financial statements for either Valley Forge or the Company.
Thus, there were no disagreements with RMSB&G on any matter
of accounting principles or practices, financial statement
disclosure or auditing scope or procedure, which disagreements,
if not resolved to the satisfaction of RMSB&G, would have
caused it to make reference to the subject matter of the
disagreement in connection with its report. Furthermore, none of
the reportable events described in Item 304(a)(1)(v) of
Regulation S-K
occurred during RMSB&Gs engagement.
Effective October 20, 2005, the Audit Committee appointed
McGladrey as the Companys new independent registered
public accounting firm. Valley Forge did not consult with
McGladrey with respect to any of the matters or reportable
events set forth in Item 304(a)(2)(i) and (ii) of
Regulation S-K.
During McGladreys engagement, the Company did not consult
with McGladrey with respect to any of the matters or reportable
events set forth in Item 304(a)(2)(i) and (ii) of
Regulation S-K.
On January 10, 2007, the Audit Committee terminated the
engagement of McGladrey as the Companys independent
registered public accounting firm. McGladreys reports on
the Companys financial statements for the past two fiscal
years did not contain an adverse opinion or a disclaimer of
opinion, and were not qualified or modified as to uncertainty,
audit scope or accounting principles. Furthermore, no
disagreements with McGladrey on any matter of accounting
principles or practices, financial statement disclosure or
auditing scope or procedures, which disagreements, if not
resolved to the satisfaction of McGladrey, would have caused it
to make reference to the subject matter of the disagreement in
connection with its reports on the Companys financial
statements for such periods. None of the reportable events
described in Item 304(a)(1)(v) of
Regulation S-K
occurred during McGladreys engagement.
Effective January 9, 2007, the Audit Committee appointed
UHY LLP as the Companys new independent registered public
accounting firm. Prior to the aforementioned engagement, the
Company did not consult with UHY LLP with respect to any of the
matters or reportable events set forth in Item 304(a)(2)(i)
and (ii) of
Regulation S-K.
The following table shows fees billed for professional services
rendered by McGladrey for the fiscal years ended 2006 and a
portion of the fiscal year ended 2007 and UHY LLP for the
remainder of fiscal 2007:
|
|
|
|
|
|
|
|
|
|
|
Fiscal Year
|
|
|
Fiscal Year
|
|
|
|
Ended
|
|
|
Ended
|
|
|
|
July 31,
|
|
|
July 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
Audit Fees(1)
|
|
$
|
308,000
|
|
|
$
|
424,000
|
|
Audit-Related Fees
|
|
|
|
|
|
|
|
|
Tax Fees(2)
|
|
|
|
|
|
|
|
|
All Other Fees
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
308,000
|
|
|
$
|
424,000
|
|
|
|
|
(1) |
|
Audit Fees for the fiscal years ended July 31, 2007 and
2006 include services for the audit of the consolidated
financial statements, report on managements assessment of
the Companys internal control over financial reporting,
the review of the quarterly financial statements, filings of
registration statements with the SEC, comfort letters for
underwriters, consultation concerning financial accounting and
reporting standards and international statutory audits. The
amount included for the fiscal year ended July 31, 2007
includes audit fees for services rendered by McGladrey for a
portion of fiscal 2007 and is an estimate from UHY LLP for
services rendered during fiscal 2007, as the final invoice for
the year has not been rendered. |
|
(2) |
|
Tax Fees are comprised of fees relating to income tax matters,
planning and advice. |
18
Pursuant to the Audit Committees charter, all audit and
permissible non-audit services provided by the independent
registered public accounting firm must be pre-approved. These
services may include audit services, audit-related services, tax
services and other services. Pre-approval is generally provided
for up to one year and any pre-approval is detailed as to the
particular service or category of service. The independent
registered public accounting firm and management are required to
periodically report to the Audit Committee regarding the extent
of services provided by the independent registered public
accounting firm in accordance with the policies set forth in the
Audit Committee charter. Consistent with the Audit
Committees policy, all audit and permissible non-audit
services provided by McGladrey & Pullen, LLP and UHY
LLP during the fiscal years ended July 31, 2007 and 2006
were pre-approved by the Audit Committee.
In considering the nature of the services provided by the
independent registered public accounting firms, the Audit
Committee determined that such services are compatible with the
provision of independent audit services. The Audit Committee
discussed these services with the independent registered public
accounting firms and management to determine that they are
permitted under the rules and regulations concerning
auditors independence promulgated by the SEC to implement
the Sarbanes-Oxley Act of 2002, as well as rules of the American
Institute of Certified Public Accountants.
REPORT OF
THE AUDIT COMMITTEE
The Audit Committee (the Committee) oversees the
Companys financial reporting process on behalf of the
Board of Directors. Management has the primary responsibility
for the financial statements and the reporting process,
including internal control systems. The Companys
independent registered public accounting firm is responsible for
expressing an opinion on the conformity of the Companys
audited financial statements with U.S. generally accepted
accounting principles and reporting on managements
assessment of the Companys internal control over financial
reporting.
In fulfilling its oversight responsibilities, the Committee
reviewed with management the audited financial statements in the
Annual Report on
Form 10-K
for the year ended July 31, 2007, including a discussion of
the accounting principles, the reasonableness of significant
judgments and the clarity of disclosures in the financial
statements.
In addition, the Committee discussed with the independent
registered public accountants their judgments as to the
Companys accounting principles and such other matters as
are required to be discussed with the Committee under standards
of the Public Company Accounting Oversight Board (United States)
and SAS 61 (Codification of Statements on Auditing Standards).
The Committee met with the independent registered public
accountants, with and without management present, to discuss the
results of their examinations, their evaluations of the
Companys internal control over financial reporting, and
the overall quality of the Companys financial reporting.
The Committee has received from the independent registered
public accounting firm a formal written statement describing all
relationships between the firm and the Company that might bear
on the independence of the independent registered public
accounting firm consistent with Independence Standards Board
Standard No. 1 (Independence Discussions with Audit
Committees), discussed with the independent registered public
accounting firm any relationships that may impact their
objectivity and independence and satisfied itself as to their
independence.
In reliance on the reviews and discussions referred to above,
the Committee recommended to the Board of Directors (and the
Board has approved) that the audited financial statements be
included in the Annual Report on
Form 10-K
for the year ended July 31, 2007, filed with the SEC.
Submitted by the Audit Committee of the Board of Directors.
Juanita H. Hinshaw (Chairperson)
Lawrence C. Cardinale
Robert H. Dick
19
OTHER
MATTERS
Management does not know of any other business that may be
considered at the Annual Meeting. However, if any matters other
than those referred to above should properly come before the
Annual Meeting, it is the intention of the persons named in the
accompanying form of proxy to vote the proxies held by them in
accordance with their best judgment.
The Company will bear the costs of its solicitation of proxies.
In addition to the use of the mails, proxies may be solicited by
electronic mail, personal interview, telephone, telegram and
telefax by the directors, officers and employees of the Company.
Arrangements will also be made with brokerage houses and other
custodians, nominees and fiduciaries for the forwarding of
solicitation material to the beneficial owners of stock held of
record by such persons, and the Company may reimburse such
custodians, nominees and fiduciaries for reasonable
out-of-pocket expenses incurred by them in connection therewith.
FORM 10-K
Along with mailing the proxy materials, we have included a copy
of our Annual Report on
Form 10-K
for the year ended July 31, 2007. We will provide
stockholders with additional copies of our Annual Report on
Form 10-K
for the year ended July 31, 2007, without charge, upon
written request to Pamela G. Boone, Secretary, Synergetics USA,
Inc., 3845 Corporate Centre Drive, OFallon, Missouri,
63368.
HOUSEHOLDING
OF PROXY MATERIALS
The SEC has adopted rules that permit companies and
intermediaries (e.g. brokers) to satisfy the delivery
requirements for proxy statements with respect to two or more
stockholders sharing the same address by delivering a single
proxy statement addressed to those stockholders. This process,
which is commonly referred to as householding,
potentially means extra convenience for stockholders and cost
savings for companies.
A number of brokers with account holders who are stockholders
will be householding our proxy materials. As indicated in the
notice previously provided by these brokers to stockholders, a
single proxy statement will be delivered to multiple
stockholders sharing an address unless contrary instructions
have been received from an affected stockholder. Once you have
received notice from your broker or us that they will be
householding communications to your address, householding will
continue until you are notified otherwise.
Stockholders who currently receive multiple copies of the proxy
statement at their address and would like to request
householding of their communications should contact their broker
or, if a stockholder is a direct holder of shares of our common
stock, they should submit a written request to our transfer
agent, American Stock Transfer & Trust Company,
6201 15th Avenue, Brooklyn, New York, 11219. To delist
yourself from householding in the future you may write the
Company at 3845 Corporate Centre Drive, OFallon, Missouri,
63368, Attention: Pamela G. Boone. Upon request, we will
deliver promptly a separate copy of the proxy statement.
20
STOCKHOLDER
PROPOSALS FOR 2008 ANNUAL MEETING OF STOCKHOLDERS
Stockholder proposals submitted for inclusion in the proxy
statement and form of proxy for the 2008 Annual Meeting of
Stockholders must be received at the corporate offices of the
Company, addressed to the attention of Ms. Pamela G. Boone,
Secretary, Synergetics USA, Inc. no later than July 2,
2008. The proposals must comply with the rules of the SEC
relating to stockholder proposals. The Companys Bylaws
provide that no business may be brought before an annual meeting
unless specified in the notice of meeting, brought before the
meeting by or at the direction of the Board of Directors, or
otherwise brought by a stockholder who has delivered notice to
the Company (containing certain information specified in the
Bylaws) not less than 60 or more than 90 days before the
anniversary date of the immediately preceding annual meeting of
stockholders. Therefore, for the 2008 Annual Meeting of
Stockholders, such notice must be delivered no earlier than
September 7, 2008 and no later than October 8, 2008. A
copy of the full text of these Bylaw provisions may be obtained
by writing to the Secretary at the address indicated above.
By Order of the Board of Directors,
PAMELA G. BOONE
Secretary
November 13, 2007
21
SYNERGETICS USA, INC. PROXY SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS OF SYNERGETICS USA,
INC. FOR THE ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON DECEMBER 6, 2007 The undersigned, having
received the notice and accompanying Proxy Statement for said meeting, hereby appoints Gregg D.
Scheller and Pamela G. Boone, and each of them, with full power of substitution, as the
undersigneds proxy and attorney-in-fact to vote at the Annual Meeting of Stockholders of
Synergetics USA, Inc. (the Company) to be held on December 6, 2007 (the Annual Meeting), or at
any adjournment thereof, all shares of voting stock of the Company which the undersigned may be
entitled to vote. The above proxies are hereby instructed to vote as shown on the reverse of this
card and in their discretion upon such other business as may properly come before the Annual
Meeting or at any adjournment thereof. (Continued and to be signed on the reverse side.) |
ANNUAL MEETING OF STOCKHOLDERS OF SYNERGETICS USA, INC. December 6, 2007 Please date, sign and mail
your proxy card in the envelope provided as soon as possible. Please detach along perforated line
and mail in the envelope provided. 20230000000000001000 9 120607 The Board of Directors recommends
a vote FOR all director nominees and Proposal 2. PLEASE SIGN, DATE AND RETURN PROMPTLY IN THE
ENCLOSED ENVELOPE. PLEASE MARK YOUR VOTE IN BLUE OR BLACK INK AS SHOWN HERE x FOR AGAINST ABSTAIN
1. Election of Directors: 2. Ratification of the appointment of UHY LLP as independent registered
public accounting firm: NOMINEES: FOR ALL NOMINEES O Lawrence C. Cardinale This proxy, when
properly executed, will be voted in the manner directed herein O Guy R. Guarch by the undersigned
stockholder. IF NO DIRECTION IS MADE, THIS PROXY WILL WITHHOLD AUTHORITY BE VOTED FOR ALL
PROPOSALS. FOR ALL NOMINEES PLEASE SIGN, DATE AND RETURN THIS PROXY PROMPTLY USING THE FOR ALL
EXCEPT (See instructions below) ENCLOSED ENVELOPE EVEN IF YOU PLAN TO ATTEND THE MEETING.
INSTRUCTION: To withhold authority to vote for any individual nominee(s), mark FOR ALL EXCEPT and
fill in the circle next to each nominee you wish to withhold, as shown here: MARK X HERE IF YOU
PLAN TO ATTEND THE MEETING. To change the address on your account, please check the box at right
and indicate your new address in the address space above. Please note that changes to the
registered name(s) on the account may not be submitted via this method. Signature of Stockholder
Date: Signature of Stockholder Date: Note: Please sign exactly as your name or names appear on this
Proxy. When shares are held jointly, each holder should sign. When signing as executor,
administrator, attorney, trustee or guardian, please give full title as such. If the signer is a
corporation, please sign full corporate name by duly authorized officer, giving full title as such.
If signer is a partnership, please sign in partnership name by authorized person. |